| Financial Year |
March 31 2023 |
| Monetary Funds |
657,242,545.48 |
| Held-for-trading Financial Assets |
733,418,879.58 |
| Notes Receivable |
3,500,000.00 |
| Accounts Receivable |
1,344,107,287.87 |
| Advances to Suppliers |
79,245,496.30 |
| Other Receivables |
24,474,646.83 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
660,526,870.21 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
12,402,423.03 |
| Other Current Assets |
13,689,934.41 |
| Total Current Assets |
3,528,608,083.71 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
8,076,290.09 |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
899,795,215.62 |
| Under-construction Projects |
60,141,704.38 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
174,465,442.09 |
| R&D expenses |
-- |
| Goodwill |
20,263,358.77 |
| Long-Term Deferred and Prepaid Expenses |
3,994,144.84 |
| Deferred Income Tax Assets |
111,701,811.94 |
| Other Non-Current Assets |
43,228,440.80 |
| Sub-Total of Non-Current Assets |
1,321,749,576.37 |
| Total Assets |
4,850,357,660.08 |
| Short-Term Loans |
1,267,126,354.55 |
| Trading Financial liabilities |
-- |
| Notes Payable |
231,803,956.65 |
| Accounts Payable |
259,982,924.99 |
| Accounts Received In Advance |
1,400,000.00 |
| Employee Compensation Payable |
21,652,867.58 |
| Taxes Payable |
12,598,906.93 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
8,869,685.75 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
6,842,582.01 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
2,099,169,485.50 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
16,763,550.57 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
41,451,981.45 |
| Total Liabilities |
2,140,621,466.95 |
| Paid-In Capital(Or Share Stock) |
700,000,000.00 |
| Capital Surplus |
643,050,330.49 |
| Surplus Reserve |
123,442,433.76 |
| LESS:Treasury Stock |
30,681,916.00 |
| Undistributed Profits |
1,277,918,730.21 |
| Minority Stockholder's Interest |
-3,993,385.33 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,713,729,578.46 |
| Owner's Equity（Stockholder's Equity） |
2,709,736,193.13 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,850,357,660.08 |
